chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up and could not feel my feet completely. Called doc off at Medical and had a telehealth appointment with. I explained that I had had the COVID booster 5 days before and not sure if it was reported. She placed me on gabapentin for neuropathy due to possible sciatic issues and it helped slightly- changed providers. Was sent for X-rays, MRI, blood work.
Fever; Body aches; Nausea; Vomiting; Headache; This is a spontaneous report from a contactable nurse (patient).  A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration first dose on 28Dec2020 at single dose for covid-19 immunisation. The patient's medical history Covid-19 from Apr2020. The patient's concomitant medications were not reported. On an unspecified date, the patient would like to know if she should receive the second dose of the Pfizer COVID-19 vaccine after having an adverse reaction with her first dose of the COVID-19 vaccine. The patient experienced "fever, body aches, nausea, vomiting, headache, all that stuff and it lasted about 5 or 6 days. The patient had to miss work for a couple of days. The patient did not have any anaphylactic type reactions though. The outcome of the events was unknown.  Information about batch/lot number has been requested.
ACUTE NON ST ELEVATION MI 8/12/2022 ATRIAL FIBRILLATION, UNSPECIFIED TYPE 2 MI 8/9/2022 ATRIAL FIBRILLATION, UNSPECIFIED ACUTE NON ST ELEVATION MI 8/12/2022 ACUTE NON ST ELEVATION MI TYPE 2 MI 8/9/2022 ACUTE NON ST ELEVATION MI
pt c/o feet cramping & toes draws but the past few months cramping became more intense to the point of having to take shoe  off to work w/foot;
Post vax, the pt developed lack of mobility in extremities, loss of muscular nerve functions, blurred vision, cataracts, and  pain in all joints. Treatment included medication. Follow up information received 09/18/02 states "Pain in all joints of body (ie- neck, arms, legs(Knees), Difficulty in walking, getting up from sitting positions, Sleep is affected, fatigue, general weakness over entire body, conditions gets worst each month.".
Bruising, itching, and small bumps at the injection site; Bruising, itching, and small bumps at the injection site; Bruising, itching, and small bumps at the injection site; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6204), via an unspecified route of administration in the left arm on 18Mar2021 at 14:30 (at the age of 18-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021, the patient experienced bruising, itching, and small bumps at the injection site. The patient did not receive any treatment for reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vaccination site bruising, vaccination site pruritus, and vaccination site lump was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Headache; Nausea; Vomiting; Fatigue/ Tired; Difficulty standing; This case was reported by a nurse via sales rep and described the occurrence of headache in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On 3rd September 2019, the patient received Bexsero. In September 2019, less than a day after receiving Bexsero, the patient experienced headache, nausea, vomiting, fatigue and difficulty in standing. On an unknown date, the outcome of the headache, nausea, vomiting, fatigue and difficulty in standing were recovering/resolving.   It was unknown if the reporter considered the headache, nausea, vomiting, fatigue and difficulty in standing to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that within 12 hours of receiving the Bexsero patient experienced headache, nausea, vomited once, felt fatigue and tired that she could not even stand up. The patients condition was slowly improving. No further details were provided.
Pt had increase stooling 3 days prior to hospitalization. There was no bowel movement the next day but increased fussiness. By on night prior to admission baby refused pacifier and only liked upright position. Patient seen in our office and sent to hospital to r/o intussusception. KUB, labs normal but heme (+) stool noted. Patient admitted for observation and Ba enema done due to increased fussiness and intussusception diagnosed. Baby recovered well and discharged home 2 days later. 8/26/08-DC summary received for DOS 8/22/08-DC DX: Intussusception. Admitted with C/O irritability. 9/5/08-records received for DOS 8/20-8/22/08-presented to ED with 3 day history of fussy, crying difficult to console, minimal stool output. Breastfeeding until 2 nights ago when rice cereal was introduced. Abdomen hard with poor bowel sounds.
Developed local raction with redness and tenderness at the injection site (left upper arm). Local reaction symptoms were diffuse myalgias and extreme tenderness of left upper arm as well as left neck.
Patient was given a Moderna vaccine. Due to age of patient they should have been given a Pfizer vaccine
p/vax reported that w/in 3hr post vax pt exp itchy, wheezing, throat closing, trouble breathing, took Dimetapp lasting x 2hr then resolved;
First, mild chest/bronchial tightening, and mild difficulty breathing.  As these reactions eased, at about 10:00 PM, I began to have very significant chills and shivering with mild achiness which lasted about two hours.  Then uneasy tossing and turning the rest of the night.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a health care professional concerned a 35 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A expiry: 21-SEP-2021) dose was not reported, administered on 28-SEP-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 28-SEP-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20210960415 and 20210960389.
Event occurred after 3rd vaccine which was given 11/9/21 no lot number recorded
Pt states approximately 1 week after vaccine her upper arm became very itchy. Reports taking OTC benadryl to control the itching. Pt came into the office, left upper arm red and slightly swollen. Pt instructed to see PCP for recommendations other than benadryl. Pt states she is going there when she leaves here.
Eignt days after, slept as muchas 13-14 hours (normally 7.5 hours).; shingles; tired; No stamina; Thinking is slower; joint stiffness in am; muscle aches; burning sensations in palms and lower legs; ribs ache; This is a spontaneous report received from a contactable healthcare professional, the patient. A 65-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 20Mar2021 at 14:45 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included shingles and lyme disease. The patient was known allergic to codeine (MANUFACTURER UNKNOWN), jellyfish and latex. The patient did not receive any medication within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021, within 48 hours, the patient experienced shingles, increasingly tired over the next 12 days. On 28Mar2021, eight days after the vaccination, the patient slept as much as 13-14 hours (normally 7.5 hours) (hypersomnia). It was reported that the patient had no stamina, cannot work for more than a couple hours and thinking was slower than usual and had some joint stiffness. The adverse events resulted in a doctors or other healthcare visit/professional office/clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events shingles, increasingly tired,  the patient slept as much as 13-14 hours normally 7.5 hours , no stamina, thinking was slower, joint stiffness in arm, muscle aches, burning sensations in palms and lower legs and ribs ache was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
We found other cases of HLH post-COVID vaccination, including patients that received the Moderna vaccine./11 VAERS reports of the HLH condition after the Moderna vaccine.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (We found other cases of HLH post-COVID vaccination, including patients that received the Moderna vaccine./11 VAERS reports of the HLH condition after the Moderna vaccine.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (We found other cases of HLH post-COVID vaccination, including patients that received the Moderna vaccine./11 VAERS reports of the HLH condition after the Moderna vaccine.) (seriousness criterion medically significant). At the time of the report, HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (We found other cases of HLH post-COVID vaccination, including patients that received the Moderna vaccine./11 VAERS reports of the HLH condition after the Moderna vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The reporter stated that they found in Vaers 11 reports of the HLH condition after the Moderna vaccine.   No concomitant product information was provided by the reporter.  No treatment information was provided by the reporter.  Company comment: Very scant information is given and follow-up is requested. Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow-up information included no new information.; Sender's Comments: Very scant information is given and follow-up is requested. Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
After the shot, I spoke to the nurse for about a minute, sitting in the chair. They did not have an observation area and told me it was ok to leave (also, I explained my only symptoms after shots 1 and 2 was soreness at the injection site and a bit of fatigue the next day). I stood up to walk out, and about 10-15 steps from the chair I experienced something I've never felt before and am having a hard time describing. My whole body (mostly head and torso) felt extremely hot, I felt something akin to dizziness (though not exactly dizziness), and pain (similar to an ache), and sort of like I was hard inside (yeah this is hard to explain). It felt like all of this (the heat, the woozy feeling, and the pain) was deep inside, and radiating outward. I didn't feel like I was going to faint, but I did feel I shouldn't just walk out and try to go home.  I returned to one of the nurses, and could not accurately describe what was happening. At this point, about 3-4 minutes at most after the shot, the nurse asked if I was feeling flush. At that point, my neck and face felt extremely warm. I'm 55 years old and have been through menopause and still have hot flashes--this was a level of heat I've never experienced. I sat down and within a minute or two felt fine. I waited about 10-12 minutes, then left. Since there was no official observation area, no one was watching me and I didn't know if I should check in with them before I left, so I just left and went home. Other than that experience, the only difference with this booster (from my two original shots)  was that I woke up in the middle of the night with a migraine headache (which I haven't had one in years). I spoke with a nurse at my own doctor's office and was told they didn't know what the symptoms were, they weren't on the list of side effects and didn't suggest to them anything else was specifically wrong with me; and  they weren't concerned given that I feel fine now. But to call them if I experienced it again.
Less than 10 minutes after vaccines were administered pt c/o blurred vision with seeing white spots, feeling shaky, and some dizziness. Pt was brought back to the room again and given water and an IM injection of 25mg Benadryl. Pt sat in the room until his wife came to pick him up.
10-11 Into HD C/O swelling in bicep and tricep has hot red rash over the area & now swelling is progressing down to wrist. Hx acute lymphocytic leukemia Dr suggested put ice on it, elevate over heart, not drive, take Benadryl & see own HCP ASAP. Spoke to him a couple days later and the swelling was gradually going away.
ALT increased; AST increased; Vertigo; This is a spontaneous report from a contactable healthcare professional, the patient.  A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 07Jan2021 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included Megoblastic Macrocytic Anemia. Concomitant medications was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the arm left on 16Dec2020 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10May2021, 4 months later, patient had elevated liver enzymes ALT and AST. Patient had no known history and did not drink not obese, never elevated. Also the patient dealing with horrible vertigo. She spoke to 3 other people she know 2 in the same department that have the same thing going on and she was questioning whether it is a possible side effect? The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event ALT increased, AST increased and vertigo were not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number can not be obtained.
Vaccinated 3/19 lot # ER 2613 had red rash on upper chest 3/20 itchy, then 3/21 rash on right ankle itchy contacted doctor went to se her 3/23 provided abx ointment could not determine if from vaccine or insect bites said I could have second dose just premeditate again . Had 2nd dose 4/14 lot # EW 0162  at 2:15 pm had rash at  3:30 pm on top of left foot itchy, chest, back of right shoulder. Took 50 mg diphenhydramine on 4/14 at 3:30 rash on chest start to clear up other rashes treated with triple abx ointment.
pt diagnosed positive for COVID on 8/9/21, brought to hospital but was discharged due to normal O2 sats and negative chest xray; returns to hosp through ED on 8/12/21 with increasing confusion, weakness and decreased oral intake; diagnosed with COVID, failure to thrive, and metabolic encephalopathy; due to declining health family decided to make pt comfort measures and have him transferred to Hospital; pt died in Hospital
Patient had vasovagal response after receiving vaccine. Lost consciousness for approximately 60 seconds. Vital signs stable. Monitored for 40 minutes and driven home by friend.
1120 pt recvd vax & 120 PC from father states pt having convuls-pt's shaking; referred to ER for medical attention; pt exp high fever;
Chills started first followed by high fever, which lasted about 10 hours. Tachycardia around 100beats/min, symptoms alleviated by Tylenol.  Observed pain, swelling, redness and tenderness at injection site.
VASCULAR INFLAMMATION; VERTIGO; DEBILITATING HEADACHES; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced vascular inflammation, vertigo, and debilitating headaches. The action taken with covid-19 vaccine  was not applicable. The patient was recovering from vascular inflammation, debilitating headaches, and vertigo. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Patient has deep red, warm, painful "rash spots" on the front and back of left arm approximately 5 inches below the injection site. She went to Dr and he gave her antibiotic and pain medicine.
sickness; chills; Headache; very tired; hip hurts; Depression; has no energy; Vaccine received on top of shoulder on outside ball; taste loss; Covid-19; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), AGEUSIA (taste loss), RHINORRHOEA (Runny nose) and ILLNESS (sickness) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     Concomitant products included WARFARIN for DVT, TOPIRAMATE (TOPAMAX) for Headache, VENLAFAXINE HYDROCHLORIDE (EFFEXOR SR) and CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]) for an unknown indication.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced RHINORRHOEA (Runny nose). On 15-Aug-2021, the patient experienced COVID-19 (Covid-19). On an unknown date, the patient experienced AGEUSIA (taste loss) and ILLNESS (sickness). At the time of the report, COVID-19 (Covid-19), AGEUSIA (taste loss), RHINORRHOEA (Runny nose) and ILLNESS (sickness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She was tested positive for COVID-19 on 15-Aug-2021. Treatment was not specified.   This case was linked to MOD-2021-299980 (Patient Link).
Patient called 7/30/10 to report that after Shingles vaccine she developed a red (size of golfball) area at injection site.  At time of call redness still persisted but smaller.
I had very severe pain of my right eye and eye ball that radiated into the back of my head. My optometrist diagnosed conjunctivitis with no bacteria or virus present and prescribed steroid drops. She said she had seen this reaction after COVID vaccination several times.
A LOT OF PAIN IN ARM; FEVER; This spontaneous report received from a parent concerned a 23 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sinus allergy, non alcoholic, and non smoker, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug usage. the patient had some allergies.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 30-MAY-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported. On 30-MAY-2021, the subject experienced a lot of pain in arm. On 30-MAY-2021, the subject experienced fever. Laboratory data included: Fever (NR: not provided) 99.8 F. On 31-MAY-2021, Laboratory data included: Fever (NR: not provided) 101.8 F. On 02-JUN-2021, Laboratory data included: Fever (NR: not provided) 99.1 F, 101 F. The action taken with covid-19 vaccine  was not applicable. The patient was recovering from fever, and a lot of pain in arm. This report was non-serious. This case, from the same reporter is linked to 20210604932.
Narrative:  DIARRHEA IMPROVED BUT STILL HAVING SOME Symptoms: Diarrhea Treatment:
I have already had virus; I have already had virus; This is a spontaneous report received from a contactable consumer reporting for herself via medical information team. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for OVID-19 immunization. Medical history and concomitant medications were not reported. The patient stated "I have already had virus." The outcome of the event was unknown. Information on the lot/batch number has been requested.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 02-MAY-2016 the patient was vaccinated with an improperly stored dose of GARDASIL (lot # L040460, expiration date 27-MAY-2017, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 80 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Arm soreness at injection site.; This is a spontaneous report from a non- contactable consumer. A 54-years-old male patient started to receive bnt162b2 (COVID-19 MRNA VACCINE BIONTECH), via an unspecified route of administration on 13Jan2021 08:45 at single dose (lot_number=EK9231 / 4130121) on left arm for covid-19 immunisation. Medical history included heart surgery, penicillin allergy, heart failure. Patient received other medications within 2 weeks of vaccination. No other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced arm soreness at injection site on 13Jan2021 18:00. No treatment received for the event. Outcome of event was recovering.   No follow-up attempts are possible. No further information is expected.